1-4 of 4
Marlena Fejzo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 936: KRAS mutational subtypes and copy number variations are predictive of response of human pancreatic cancer cell lines to MEK162 in vitro.

Habib R. Hamidi, Richard Finn, Lee Anderson, Ming Lu, Marlena Fejzo, Charles Ginther, Ronald Linnartz, Angela Zubel
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 936.
https://doi.org/10.1158/1538-7445.AM2013-936
Published: 15 April 2013
View article titled, Abstract 936: KRAS mutational subtypes and copy number variations are predictive of response of human pancreatic cancer cell lines to MEK162 <em>in vitro</em>.
Journal Articles

RIN1 Is a Breast Tumor Suppressor Gene

Marc Milstein, Chelsea K. Mooser, Hailiang Hu, Marlena Fejzo, Dennis Slamon, Lee Goodglick, Sarah Dry, John Colicelli
Journal: Cancer Research
Cancer Res (2007) 67 (24): 11510–11516.
https://doi.org/10.1158/0008-5472.CAN-07-1147
Published: 18 December 2007
View article titled, RIN1 Is a Breast Tumor Suppressor Gene
Open the PDF for RIN1 Is a Breast Tumor Suppressor Gene in another window
Includes: Supplementary data
Journal Articles

Neutralizing monoclonal antibodies to periostin for ovarian cancer therapy

Min Zhu, Romaine Saxton, Marlena Fejzo, Lee Anderson, Charles Ginther, David Chang, Beth Karlan, Judith Gasson, Dennis Slamon
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4096.
Published: 01 May 2007
View article titled, Neutralizing monoclonal antibodies to periostin for ovarian cancer therapy
Journal Articles

Analysis of 20q genes in ovarian cancer by microarray identifies potential targets for screening and therapy

Marlena Fejzo, Chuck Ginther, Judy Dering, Lee Anderson, Lillian Ramos, Christine Walsh, Beth Karlan, Dennis Slamon
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4444.
Published: 01 May 2007
View article titled, Analysis of 20q genes in ovarian cancer by microarray identifies potential targets for screening and therapy